Cost-effectiveness of pramipexole in Parkinson's disease in the United States

被引：0
|
作者：
Hoerger, TJ
Bala, MV
Rowland, C
Greer, M
Holloway, R
机构：
来源：
NEUROLOGY | 1998年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P05109
引用
收藏
页码：A298 / A299
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [2] Cost-effectiveness of treatment with entacapone for patients with Parkinson's disease in the United States
    Palmer, C
    Nuijten, M
    Schmier, J
    Subedi, P
    Snyder, E
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (03) : 496 - 496
  • [3] Cost-effectiveness of pramipexole compared with piribedil in early Parkinson's disease patients
    Chikina, ES
    Gusev, EL
    Belousov, YB
    Guecht, AB
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 321 - 321
  • [4] Cost effectiveness of pramipexole in Parkinson's disease in the US
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Chrischilles, EA
    Holloway, RG
    [J]. PHARMACOECONOMICS, 1998, 14 (05) : 541 - 557
  • [5] Cost Effectiveness of Pramipexole in Parkinson’s Disease in the US
    Thomas J. Hoerger
    Mohan V. Bala
    Clayton Rowland
    Marianne Greer
    Elizabeth A. Chrischilles
    Robert G. Holloway
    [J]. PharmacoEconomics, 1998, 14 : 541 - 557
  • [6] Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States
    Pietzsch, Jan B.
    Garner, Abigail M.
    Marks, William J., Jr.
    [J]. NEUROMODULATION, 2016, 19 (07): : 689 - 697
  • [7] COST-EFFECTIVENESS ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A757 - A757
  • [8] Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States
    Palmer, CS
    Nuijten, MJC
    Schmier, JK
    Subedi, P
    Snyder, EH
    [J]. PHARMACOECONOMICS, 2002, 20 (09) : 617 - 628
  • [9] Cost Effectiveness of Treatment of Parkinson’s Disease with Entacapone in the United States
    Cynthia S. Palmer
    Mark J.C. Nuijten
    Jordana K. Schmier
    Prasun Subedi
    Edward H. Snyder
    [J]. PharmacoEconomics, 2002, 20 : 617 - 628
  • [10] Cost-Effectiveness of Carbidopa-Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States
    Pahwa, Rajesh
    Merola, Aristide
    Soileau, Michael
    Alobaidi, Ali
    Pickard, A. Simon
    Kandukuri, Prasanna L.
    Bao, Yanjun
    Strezewski, John
    Oddsdottir, Julia
    Xu, Weiwei
    Standaert, David
    [J]. MOVEMENT DISORDERS, 2023, 38 (12) : 2308 - 2312
12345